Clinical Trials
2 trialsNCT00598507 2013-12-11
Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT00496379 2013-03-14
ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases
Dana-Farber Cancer Institute
Phase 2 Terminated